Literature DB >> 26021471

Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia.

Mohammad Faizan Zahid1, Natasha Ali.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26021471     DOI： 10.1007/s12032-015-0632-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  9 in total

Review 1.  Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens.

Authors:  Mohamed A Kharfan-Dabaja; Ali Bazarbachi
Journal:  Cancer Control       Date:  2012-01       Impact factor: 3.302

Review 2.  Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic leukemia.

Authors:  Issa F Khouri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

3.  Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia.

Authors:  Carol Moreno; Neus Villamor; Dolors Colomer; Jordi Esteve; Eva Giné; Ana Muntañola; Elias Campo; Francesc Bosch; Emili Montserrat
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

4.  Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

Authors:  P Dreger; P Corradini; E Kimby; M Michallet; D Milligan; J Schetelig; W Wiktor-Jedrzejczak; D Niederwieser; M Hallek; E Montserrat
Journal:  Leukemia       Date:  2006-11-16       Impact factor: 11.528

5.  Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

Authors:  Peter Dreger; Hartmut Döhner; Matthias Ritgen; Sebastian Böttcher; Raymonde Busch; Sascha Dietrich; Donald Bunjes; Sandra Cohen; Jörg Schubert; Ute Hegenbart; Dietrich Beelen; Matthias Zeis; Michael Stadler; Justin Hasenkamp; Lutz Uharek; Christof Scheid; Andreas Humpe; Thorsten Zenz; Dirk Winkler; Michael Hallek; Michael Kneba; Norbert Schmitz; Stephan Stilgenbauer
Journal:  Blood       Date:  2010-07-01       Impact factor: 22.113

6.  Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis.

Authors:  P Dreger; R Brand; D Milligan; P Corradini; J Finke; G Lambertenghi Deliliers; R Martino; N Russell; A van Biezen; M Michallet; D Niederwieser
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

Review 7.  Role of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a review.

Authors:  Prerna Mewawalla; Sunita Nathan
Journal:  Ther Adv Hematol       Date:  2014-10

8.  Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.

Authors:  Issa F Khouri; Rima M Saliba; Joan Admirand; Susan O'Brien; Ming-S Lee; Martin Korbling; Barry I Samuels; Sergio Giralt; de Marcos Lima; Michael J Keating; Richard E Champlin; Carlos Bueso-Ramos
Journal:  Br J Haematol       Date:  2007-05       Impact factor: 6.998

9.  Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome.

Authors:  J R Brown; H T Kim; P Armand; C Cutler; D C Fisher; V Ho; J Koreth; J Ritz; C Wu; J H Antin; R J Soiffer; J G Gribben; E P Alyea
Journal:  Leukemia       Date:  2012-08-14       Impact factor: 11.528
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.